Product
Help
Pricing
About
Jobs
Log in
Get started
Author
Add to collection
T Schuster
Observed names:
T. Schuster,
T.B. Schuster,
Tobias Schuster
Institution:
Bühlmann (Switzerland)
Observed institutions:
HHL Leipzig Graduate School of Management,
TUM Klinikum,
Bühlmann (Switzerland),
Technical University of Munich
ORCID:
0009-0006-7318-7031
Observed ORCID:
0009-0006-7318-7031
OpenAlex ID:
A5008817677
Leadership’s long arm: The positive influence of digital leadership on managing technology-driven change over a strengthened service innovation capacity
2023
·
Timo J. J. Brunner
, Tobias Schuster
, et al.
·
Frontiers in Psychology
·
152
PDF
Knollenblätterpilzvergiftung
2008
·
M Ganzert
, N Felgenhauer
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
65
Lebensbedrohliche Komplikationen von Morbus Crohn und Colitis ulcerosa
2010
·
W Huber
, G Herrmann
, et al.
·
DMW - Deutsche Medizinische Wochenschrift
·
19
Treatment preferences of hospitalized medical patients for life-sustaining interventions and intensive care unit admission
2015
·
M. Messer
, W. Huber
, et al.
·
British Journal of Anaesthesia
·
6
A-085 Analytical Performance of BÜHLMANN sCAL® turbo, a New, Reliable and Precise High-Throughput Assay to Assess the Inflammatory Status of Patients
2023
·
A Melone
, D Vogt
, et al.
·
Clinical Chemistry
·
1
PDF
Analytical Performance of BÜHLMANN fPELA® turbo, a Fecal Pancreatic Elastase PETIA Assay
2020
·
I. Winter
, D. Guschin
, et al.
·
Pancreatology
·
1
P283 Quantum blue® adalimumab: development of the first point of care rapid test for therapeutic drug monitoring of serum adalimumab levels
2017
·
F.I. Bantleon
, S. Kräuchi
, et al.
·
Journal of Crohn s and Colitis
·
1
Performance evaluation of the BÜHLMANN CALEX® FIT stool extraction device
2026
·
D. Guschin
, A. Ohmann
, et al.
·
Clinica Chimica Acta
Analytical performance of BÜHLMANN fHB® turbo, a fecal hemoglobin PETIA assay
2026
·
D. Guschin
, S. Rudy
, et al.
·
Clinica Chimica Acta
P0419 Clinical Evaluation and method comparison of four fecal calprotectin assays
2026
·
C Reinhard
, M E Ueberschlag
, et al.
·
Journal of Crohn s and Colitis
Validation analytique et études de stabilité pour un test d’activation des basophiles commercial certifié IVDR
2025
·
A. Leathers
, C. Shaw
, et al.
·
Revue française d'allergologie
A-087 Stability of fecal calprotectin extracted with BÜHLMANN CALEX® Cap
2024
·
C Shaw
, A Voitl
, et al.
·
Clinical Chemistry
Clinical performance of a turbidimetric immunoassay for the quantification of fecal pancreatic elastase
2024
·
D. Trapani
, U. Aldinger
, et al.
·
Clinica Chimica Acta
Regulatory conform replacement of triton-x in an anti-mag antibodies ELISA – The impact of different detergents on performance and stability
2024
·
S. Bantleon
, M. Überschlag
, et al.
·
Clinica Chimica Acta
P437 Feasibility study of a Point-of-Care assay for rapid determination of anti-TNFα biologics in capillary blood
2024
·
B Ricken
, L Brosi
, et al.
·
Journal of Crohn s and Colitis
PDF
P473 Comparison of clinical performance of fecal calprotectin of laboratory methods with lateral flow based POC and home tests
2024
·
C Reinhard
, R Pénager
, et al.
·
Journal of Crohn s and Colitis
PDF
Ab1692 a New, Reliable and Precise High-throughput Serum Calprotectin Assay to Assess the Inflammatory Status of Patients
2023
·
A. Melone
, D. Vogt
, et al.
·
Annals of the Rheumatic Diseases
PDF
P149 Novel capillary blood point-of-care test for adalimumab and infliximab trough levels: Effects of abnormal blood conditions on the test result
2023
·
L Brosi
, C Reinhard
, et al.
·
Journal of Crohn s and Colitis
P229 Standardization of Quantum Blue® rapid TDM assays with WHO international standards for adalimumab and infliximab
2021
·
J Afonso
, B Ricken
, et al.
·
Journal of Crohn s and Colitis
PDF
Ab1110 Quantum Blue® Rapid Tdm Assay Standardization Highly Correlates With Who International Standard for Infliximab
2020
·
E. Keller
, P. Spies
, et al.
·
Annals of the Rheumatic Diseases
PDF
P323 Successful validation of the quantum blue quantitative rapid test to monitor C-reactive protein in capillary blood of patients suffering from chronic inflammatory diseases
2020
·
M Takacs
, A Hellige
, et al.
·
Journal of Crohn s and Colitis
PDF
P639 Validation of the Quantum Blue® infliximab-level rapid test in clinical practice of patients with inflammatory bowel disease
2018
·
A Strik
, T Schuster
, et al.
·
Journal of Crohn s and Colitis
P767 Quantum Blue® infliximab POC user performance evaluation
2018
·
B Fellay
, M Kopertowska-Majchrzak
, et al.
·
Journal of Crohn s and Colitis
Show more works
View as search
Works count:
23
Citation count:
245
H-index:
4
I10-index:
3
Year
Topic
Type